Oxford BioDynamics (LON:OBD) Trading Down 6.7% – Should You Sell?

Oxford BioDynamics Plc (LON:OBD)’s stock price traded down 6.7% during trading on Thursday . The company traded as low as GBX 1.30 ($0.02) and last traded at GBX 1.40 ($0.02). 677,375 shares changed hands during mid-day trading, a decline of 64% from the average session volume of 1,873,925 shares. The stock had previously closed at GBX 1.50 ($0.02).

Oxford BioDynamics Stock Performance

The company has a debt-to-equity ratio of 370.22, a current ratio of 0.68 and a quick ratio of 2.80. The stock’s 50-day moving average is GBX 1.27 and its 200 day moving average is GBX 4.10. The stock has a market cap of £3.74 million, a price-to-earnings ratio of -20.00 and a beta of 0.42.

Insider Activity

In related news, insider David Holbrook purchased 49,653 shares of the stock in a transaction dated Monday, October 28th. The shares were acquired at an average cost of GBX 1 ($0.01) per share, with a total value of £496.53 ($616.81). Insiders own 16.78% of the company’s stock.

Oxford BioDynamics Company Profile

Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and the United Kingdom. The company provides EpiSwitch, a proprietary technology platform that enables screening, evaluation, validation, and monitoring of 3D genomic biomarkers to diagnose patients.